Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D F Mesitskaya

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Terapevticheskii Arkhiv|June 2, 2015
[Positive effect of low-activity thromboxane A synthase gene on prognosis in coronary heart disease]F Yu Kopylov, D F Mesitskaya, Yu M Nikitina, et al.
Kardiologiia|April 10, 2024
Determining The Risk of Atrial Fibrillation Paroxysm in Patients With Chronic Heart Failure With Intact and Reduced Ejection FractionI P Zakharov, P Sh Chomakhidze, F Yu Kopylov, et al.
Kardiologiia|July 27, 2021
Results of Register in Patients with Acute Coronary Syndrome and Atrial Fibrillation Receiving RivaroxabanO А Baturina, D A Andreev, D I A Sychev, et al.
Kardiologiia|March 12, 2019
H E El Manaa, D Yu Shchekochikhin, M S Shabanova, et al.
Kardiologiia|September 11, 2023
The use of Dapagliflozin in Acute Decompensated Heart Failure: Results of the Randomized StudyK V Charaya, D Itri Yu Schekochikhin, T V Nikiforova, et al.
Kardiologiia|September 12, 2023
The use of Dapagliflozin in Acute Decompensated Heart Failure: Results of the Randomized StudyK V Charaya, D Yu Schekochikhin, T V Nikiforova, et al.
Kardiologiia|June 12, 2023
[Remote Monitoring of the QT Interval During Polychemotherapy]Z Z A Fashafsha, P Sh Chomakhidze, D F Mesitskaya, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Terapevticheskii Arkhiv|June 2, 2015
[Positive effect of low-activity thromboxane A synthase gene on prognosis in coronary heart disease]F Yu Kopylov, D F Mesitskaya, Yu M Nikitina, et al.
Kardiologiia|April 10, 2024
Determining The Risk of Atrial Fibrillation Paroxysm in Patients With Chronic Heart Failure With Intact and Reduced Ejection FractionI P Zakharov, P Sh Chomakhidze, F Yu Kopylov, et al.
Kardiologiia|July 27, 2021
Results of Register in Patients with Acute Coronary Syndrome and Atrial Fibrillation Receiving RivaroxabanO А Baturina, D A Andreev, D I A Sychev, et al.
Kardiologiia|March 12, 2019
H E El Manaa, D Yu Shchekochikhin, M S Shabanova, et al.
Kardiologiia|September 11, 2023
The use of Dapagliflozin in Acute Decompensated Heart Failure: Results of the Randomized StudyK V Charaya, D Itri Yu Schekochikhin, T V Nikiforova, et al.
Kardiologiia|September 12, 2023
The use of Dapagliflozin in Acute Decompensated Heart Failure: Results of the Randomized StudyK V Charaya, D Yu Schekochikhin, T V Nikiforova, et al.
Kardiologiia|June 12, 2023
[Remote Monitoring of the QT Interval During Polychemotherapy]Z Z A Fashafsha, P Sh Chomakhidze, D F Mesitskaya, et al.
Pageof 1